Allscripts to Announce Fiscal First Quarter Results on September 29, 2009; Company Appoints Vice President of Investor Relations
New Vice President of Investor Relations
Allscripts also announced that Seth Frank has joined Allscripts as Vice President, Investor Relations, reporting to Chief Financial Officer Bill Davis.
Frank brings to the new role 18 years of experience spanning healthcare, securities research, corporate investor relations and financial communications. Prior to joining Allscripts, Frank served as Vice President of Sard Verbinnen & Co., a firm providing strategic corporate, financial and crisis communications services to public and private companies.
Prior to that, Frank served as Director, Investor Relations and Finance, for Kanbay International, a Rosemont, Ill.-based global information technology services provider. His previous roles include Vice President and Manager of Institutional Equity Sales for A.G. Edwards and Sons in St. Louis, where he also served as a Senior Analyst in the health care information technology sector.
Frank received a bachelor's degree from Emory University and a master's of science degree from the University of Colorado. He completed graduate coursework in health care management and policy at Yale University, where he also served as a clinical researcher and staff physician assistant.
"We are very pleased to welcome Seth to Allscripts," said Davis. "His leadership skills and industry experience will make him a trusted resource for our shareholders, analysts and potential investors. A dedicated investor relations function will be highly valuable in satisfying the increasing interest we're experiencing from the financial community."
More details on the call
The earnings announcement will be distributed via PR Newswire immediately after the market closes on the afternoon of September 29th. The press release also will be available on the company's website at www.allscripts.com.
To listen to the conference call online, participants may log onto www.allscripts.com. It is recommended that participants log onto the website approximately 15 minutes prior to the start of the conference call to download and install any necessary software. The conference call also can be accessed by dialing 877-230-5050 and requesting the Allscripts investor presentation (973-532-4923 for international callers outside of the US/Canada). A Microsoft Windows Media Player web replay will be available three hours after the conclusion of the call for a period of two weeks at www.allscripts.com or by calling 800-642-1687 (706-645-9291 for international callers) - ID # 27582277.
(Minimum requirements to listen to the broadcast are: Microsoft Windows Media Player software, downloadable free from http://windowsmedia.com/download/download.asp, an Internet connection, and speakers or earphones).
Upcoming Investor Presentations
Allscripts will present at the following upcoming investor events:
The presentations may be accessed live or as archived files at www.allscripts.com under the "Company" menu (click "Investor Relations"). The Stifel Nicolaus/Hopkins conference does not include presentations.
Allscripts uses innovation technology to bring health to healthcare. More than 160,000 physicians, 800 hospitals and nearly 8,000 post-acute and homecare organizations utilize Allscripts to improve the health of their patients and their bottom line. The company's award-winning solutions include electronic health records, electronic prescribing, revenue cycle management, practice management, document management, hospital care management, emergency department information systems and homecare automation. Allscripts is the trade name of Allscripts-Misys Healthcare Solutions, Inc. To learn more, visit www.allscripts.com.
This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry; possible regulation of the Company's software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; our ability to identify and complete acquisitions, manage our growth and integrate acquisitions; the ability to recognize the benefits of the merger with Misys Healthcare Systems, LLC ("MHS"); the integration of MHS with the Company and the possible disruption of current plans and operations as a result thereof; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers; our ability to obtain, use or successfully integrate third-party licensed technology; breach of our security by third parties; and the risk factors detailed from time to time in our reports filed with the Securities and Exchange Commission, including our May 31, 2009 Annual Report on Form 10-K available through the Web site maintained by the Securities and Exchange Commission at www.sec.gov. The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.
-- Sept. 9, 2009 at the Thomas Weisel Partners Healthcare Conference, held in the Four Seasons, Boston -- Sept. 15, 2009 at the Stifel Nicolaus/Johns Hopkins Bloomberg School of Public Health 2009 Health Policy Conference, held in the Hilton, Baltimore -- Sept. 21, 2009 at the UBS Global Life Sciences Conference, held in the Grand Park Hyatt, New York City -- Oct. 5, 2009 at the JMP Securities Healthcare Conference, held in the Palace, New York City -- Nov. 11, 2009 at the Credit Suisse Healthcare Conference, held in the Biltmore, Phoenix -- Nov. 19, 2009 at Citi's 6th Annual Small/Mid-Cap Conference, held in Citi's Conference Center, New York City -- December 2, 2009 at Piper Jaffray Healthcare Conference, held in the Palace, New York City
SOURCE Allscripts-Misys Healthcare Solutions, Inc.
You May Also Like